Stay informed with the latest updates for the inheritable blood disorders community.

Medical
CDC Study Looks at Correlation Between Hemophilia A Inhibitors and Mortality
CDC Study Looks at Correlation Between Hemophilia A Inhibitors and…
NBDF & Community
NHF Offices Moved to New Location
NHF Offices Moved to New Location
NBDF & Community
NHF Strategic Summit Report on von Willebrand disease (VWD)
NHF Strategic Summit Report on von Willebrand disease (VWD)
Industry
Novo Nordisk Announces Launch of Novoeight®
Novo Nordisk Announces Launch of Novoeight®
Medical
CDC Findings Suggest Hemophilia Carriers Vulnerable to Joint Damage
CDC Findings Suggest Hemophilia Carriers Vulnerable to Joint Damage
NBDF & Community
Offensive Statement Removed From ABC Series Episode
Offensive Statement Removed From ABC Series Episode
NBDF & Community
Offensive Statement Removed From ABC Series Episode
ABC Hit Series Portrays Hemophilia as “Nasty Byproduct of Incest”
Medical
Small Study Shows Significant Progress in Hemophilia B Gene Therapy
Small Study Shows Significant Progress in Hemophilia B Gene Therapy
Industry
Bayer Responds to NHF-HFA Joint Statement
CSL Behring Announces Product Donations to WFH
Industry
Octapharma Announces Co-Pay Assistance for Wilate
Octapharma Announces Co-Pay Assistance for Wilate
Industry
FDA Grants Breakthrough Status to Genentech’s Investigational Therapy for Hemophilia A
Bayer Submits Application for Investigational Recombinant Factor VIII…
Advocacy & Legislative
Washington Days Draws a Crowd
Washington Days Draws a Crowd
Industry
Spark Reports Preliminary Data from Hemophilia A Gene Therapy Trial
Baxter Reports Gene Therapy Program Updates
NBDF & Community
Collaborating in Care Educational Modules Available Now
Collaborating in Care Educational Modules Available Now
Industry
Alnylam Announces Extension of Study for ALN-AT3
Biogen Idec and TIGET to Collaborate on Gene Therapy